do glp-1 cause cancer Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials Studies have shown GLP-1 medications

[1] [2] The decision to stop tirzepatide may arise from various circumstances: achievement of treatment goals, intolerable side effects, insurance coverage changes, cost considerations, pregnancy, or medical contraindications (including medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or serious hypersensitivity reactions, as noted in the boxed warning)

Gorgojo-Martnez JJ, Mezquita-Raya P, Carretero-Gmez J, et al.

A medicine supply notification issued by the Department of Health and Social Care on 27 June 2023 said the high impact shortage has been caused by an increase in demand for these products for licensed and off-label indications, with supply not expected to return to normal until at least mid-2024

We encourage you to consult with our healthcare professionals to discuss whether a semaglutide-based treatment is appropriate, effective, and safe for your specific health goals